Olfactory dysfunction in Parkinson's disease

Clinical Neuroscience

Volumn 5, Issue 2, 1998, Pages 94-101

  Wszolek, Zbigniew K ^a,b,c   Markopoulou, Katerina ^c,d  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c AMERICAN ACADEMY OF NEUROLOGY   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Familial parkinsonism; Neurodegeneration; Olfactory dysfunction; Parkinson's disease

Indexed keywords

AGING; ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GENETIC DISORDER; HUMAN; HUNTINGTON CHOREA; NEUROPATHOLOGY; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SMELLING DISORDER; SYNDROME DELINEATION;

HUMAN; NEURODEGENERATIVE DISEASES; OLFACTORY PATHWAYS; PARKINSON DISEASE; SMELL;

EID: 0032470582     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Adler CH, Gwinn KA, Newman S (1998): Olfactory function in restless leg syndrome. Mov Disord 13:563-565.
2. Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O'Brien PC, Plevak MF, Kurland LT (1998): Olfactory dysfunction in Guamanian ALS, parkinsonism and dementia. Neurology 51:1672-1677.
3. Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G (1997): Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease. Neurology 49:1424-1431.
4. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998): Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
5. Braak H, Braak E, Yilmazer D, deVos RA, Jansen EN, Bohl J, Jellinger K (1994): Amygdala pathology in Parkinson's disease. Acta Neuropathol (Berl) 88:493-500.
6. Brazis PW, Masdeu JC, Biller J (1996): Localization in clinical neurology, 3rd ed. Boston: Little, Brown. p 109-114.
7. Brunig I, Sommer M, Hatt H, Borman J (1999): Dopamine receptor subtypes modulate olfactory bulb γ-aminobutyric acid type-A receptors. Proc Natl Acad Sci USA 96:2456-2460.
8. Busenbark KL, Huber SJ, Greer G, Pahwa R, Koller WC (1992): Olfactory function in essential tremor. Neurology 42:1631-1632.
9. Bylsma FW, Moberg PF, Doty RL, Brandt J (1997): Odor identification in Huntington's disease patients and asymptomatic gene carriers. J Neuropsychiatry Clin Neurosci 9:598-600.
10. Cain WS, Rubin MD (1989): Comparability of two tests of olfactory functioning. Chem Senses 14:479-485.
11. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payami H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998): Pathogenic implications of mutations in the tau gene in pallido-pontonigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci USA 95:13103-13107.
12. Denson MA, Wszolek ZK, Pfeiffer RF, Wszolek EK, Paschall TA, McComb RD (1997): Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol 42:638-643.
13. Doty RL (1983): The smell identification test administration manual. Haddon Heights, NJ: Sensonics.
14. Doty RL (1989): Influence of age and age-related diseases on olfactory function. Ann NY Acad Sci 561:76-86.
15. Doty RL, Shaman P, Applebaum SL, Giberson R, Sikorski L, Rosenberg L (1984a): Smell identification ability: changes with age. Science 226:1441-1443.
16. Doty RL, Shaman P, Kimmelman CP, Dann MS (1984b): The University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94:176-178.
17. Doty RL, Deems DA, Stellar S (1988): Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurological signs, disease stage, or disease duration. Neurology 38:1237-1244.
18. Doty RL, Riklan M, Deems DA, Reynolds C, Stellar S (1989): The olfactory and cognitive deficits of Parkinson's disease: evidence for independence. Ann Neurol 25:166-171.
19. Doty RL, Perl DP, Steele JC, Chen KM, Pierce JD Jr, Reyes P, Kurland LT (1991): Odor identification deficit of the parkinsonism-dementia complex of Guam: equivalence to that of Alzheimer's and idiopathic Parkinson's disease. Neurology 41(Suppl 2):77-80.
20. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992a): Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138-142.
21. Doty RL, Singh A, Tetrud J, Langston JW (1992b): Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol 32:97-100.
22. Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D (1993): Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43:962-965.
23. Douek E, Bannister LH, Dodson HC (1975): Recent advances in the pathology of olfaction. Proc R Soc Med 68:467-470.
24. Duchamp-Viret P, Coronas V, Delaleu JC, Moyse E, Duchamp A (1997): Dopaminergic modulation of mitral cell activity in the frog olfactory bulb: a combined radioligand binding-electrophysiological study. Neuroscience 79:203-216.
25. Ebrahimi FA, Chess A (1998): The specification of olfactory neurons. Curr Opin Neurobiol 8:453-457.
26. Elian M (1991): Olfactory impairment in motor neuron disease: a pilot study. J Neurol Neurosurg Psychiatry 54:927-928.
27. Farrer M, Gwinn-Hardy K, Muenter M, Wavrant DeVrieze F, Crook R, Perez-Tur J, Lincoln S, Maraganore D, Adler C, Newman S, MacElwee K, McCarthy P, Miller C, Waters C, Hardy J (1999): A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet 8:81-85.
28. Gasser T, Muller-Myhsok B, Wszolek ZK, Oehlmann R, Calne DB, Bonifati V, Bereznai B, Fabrizio E, Vieregge P, Horstmann RD (1998): A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 18:262-265.
29. Hawkes CH, Shephard BC, Daniel SE (1997): Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62:436-446.
30. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997): 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39-52.
31. Hyman BT, Arriagada PV, Van Hoesen GW (1991): Pathologic changes in the olfactory system in aging and Alzheimer's disease. Ann NY Acad Sci 640:14-19.
32. Krmpotic-Nemanic J (1969): Presbycousis, presbystasis and presbyosmia as consequences of the analogous biological process. Acta Otolaryngol 67:217-223.
33. Lanza DC, Moran DT, Doty RL, Trojanowski JQ, Lee JH, Rowley JC 3rd, Crawford D, Kennedy DW (1993): Endoscopic human olfactory biopsy technique: a preliminary report. Laryngoscope 103:815-819.
34. Lanza DC, Deems DA, Doty RL, Moran D, Crawford D, Rowley JC 3rd, Sajiadian A, Kennedy DW (1994): The effect of human olfactory biopsy on olfaction: a preliminary report. Laryngoscope 104: 837-840.
35. Laurent G (1996): Dynamical representation of odors by oscillating and evolving neural assemblies. TINS 19:489-496.
36. Laurent G (1997): Olfactory processing: maps, time and codes. Curr Opin Neurobiol 7:547-553.
37. Lehrner JP, Brucke T, Dal-Bianco P, Gatterer G, Kryspin-Exner I (1997): Olfactory functions in Parkinson's disease and Alzheimer's disease. Chem Senses 22:105-110.
38. Levin BE, Katzen HL (1995): Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. Adv Neurol 65:85-95.
39. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ (1993): Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90: 8861-8865.
40. Lin DM, Ngai J (1999): Development of the vertebrate main olfactory system. Curr Opin Neurobiol 9:74-78.
41. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA (1999): Reduced expression of the G209A alpha-synuclein allele in familial parkinsonism. Ann Neurol 46:374-381.
42. Markopoulou K, Wszolek ZK, Pfeiffer RF (1995): A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38:373-378.
43. Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK (1997): Olfactory dysfunction in familial parkinsonism. Neurology 49:1262-1267.
44. Mesholam RI, Moberg PF, Mahr RN, Doty RL (1998): Olfaction in neurodegenerative disease. Arch Neurol 55:84-90.
45. Moberg PJ, Doty RL (1997): Olfactory function in Huntington's disease patients and at-risk offspring. Int J Neurosci 89: 133-139.
46. Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE (1987): Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol 9:650-664.
47. Nee LE, Scott J, Polinsky RJ (1993): Olfactory dysfunction in the Shy-Drager syndrome. Clin Auton Res 3:281-282.
48. Nordin S, Murphy C (1998): Odor memory in normal aging and Alzheimer's disease. Ann NY Acad Sci 855:686-693.
49. Nordin S, Paulsen JS, Murphy C (1995): Sensory- and memory-mediated olfactory dysfunction in Huntington's disease. J Int Neuropsychol Soc 1:281-290.
50. Pearce RK, Hawkes CH, Daniel SE (1995): The anterior olfactory nucleus in Parkinson's disease. Mov Disord 10:283-287.
51. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Dilorio G, Golbe LI, Nussbaum RL (1997): Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
52. Reyes PF, Deems DA, Suarez MG (1993): Olfactory-related changes in Alzheimer's disease: a quantitative neuropathologic study. Brain Res Bull 32:1-5.
53. Roth J, Radil T, Ruzicka E, Jech R, Tichy J (1998): Apomorphine does not influence olfactory thresholds in Parkinson's disease. Funct Neurol 13:99-103.
54. Rouquier S, Taviaux S, Trask BJ, Brand-Arpon V, van den Engh G, Demaille J, Giorgi D (1998): Distribution of olfactory receptor genes in the human genome. Nat Genet 18:243-250.
55. Sakuma K, Nakashima K, Takahashi K (1996): Olfactory evoked potentials in Parkinson's disease, Alzheimer's disease and anosmic patients. Psychiatry Clin Neurosci 50:35-40.
56. Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H (1994): Olfactory function in Parkinson's disease subtypes. Neurology 44:266-268.
57. ter Laak HJ, Renkawek K, van Workum FP (1994): The olfactory bulb in Alzheimer's disease: a morphologic study of neuron loss, tangles and senile plaques in relation to olfaction. Alzheimer's Dis Assoc Disord 8:38-48.
58. Trojanowski JQ, Newman PD, Hill WD, Lee VM (1991): Human olfactory epithelium in normal aging, Alzheimer's disease and other neurodegenerative disorders. J Comp Neurol 310:365-376.
59. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N (1995): Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 91:247-250.
60. Wszolek ZK, Pfeiffer RF, Bhatt MH, Schelper RL, Cordes M, Snow BJ, Rodnitzy RL, Wolters E, Arwert F, Calne DB (1992): Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol 32:312-320.
61. Wszolek, ZK, Cordes DB, Münter MD, Cordes I, Pfeiffer RF (1993): Hereditary Parkinson's disease: report on three families with autosomal inheritance pattern. Nervenartz 64:331-335.
62. Wszolek, ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF (1995): Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 45:502-505.
63. Zucco GM, Zaglis D, Wambsganss CS (1991): Olfactory deficits in elderly subjects and Parkinson patients. Percept Mot Skills 73:895-898.